| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 41,535 | 41,650 | 17:36 | |
| 41,560 | 41,715 | 17:35 |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 41,935 | 145 | |||
| 41,930 | 449 | |||
| 41,805 | 250 | |||
| 41,785 | 1.200 | |||
| 41,730 | 196 | |||
| 41,720 | 196 | |||
| 41,665 | 196 | |||
| 41,660 | 280 | |||
| 41,655 | 341 | |||
| 41,650 | 135 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/0qf.htm [/URL] | ||||
| 30 | 41,600 | |||
| 20 | 41,595 | |||
| 154 | 41,590 | |||
| 196 | 41,585 | |||
| 280 | 41,570 | |||
| 100 | 41,495 | |||
| 1.200 | 41,490 | |||
| 900 | 41,405 | |||
| 1.450 | 41,400 | |||
| 78 | 41,350 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 4.408 | 0,769 | 3.388 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 17:18:01 | 41,780 | 17 |
| 17:18:01 | 41,780 | 150 |
| 17:18:01 | 41,780 | 2 |
| 17:13:55 | 41,895 | 40 |
| 16:56:37 | 41,855 | 1 |
| 16:55:16 | 41,895 | 75 |
| 16:51:26 | 41,985 | 1 |
| 16:29:01 | 42,140 | 37 |
| 16:26:57 | 42,230 | 109 |
| 16:25:06 | 42,325 | 80 |
| 16:23:46 | 42,200 | 200 |
| 16:21:56 | 41,915 | 12 |
| 16:21:56 | 42,000 | 5 |
| 16:21:23 | 42,100 | 9 |
| 16:11:42 | 42,345 | 90 |
| 16:06:33 | 42,430 | 67 |
| 16:06:23 | 42,485 | 208 |
| 16:06:23 | 42,485 | 200 |
| 16:04:56 | 42,650 | 60 |
| 16:01:19 | 42,850 | 108 |
| Tagesumsatz Xetra | -4,860 -10,42 % | 8.187 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10:50 | MODERNA INC - Struktur bewahrt, Blick nach vorn | 12 | Maximilian Berger | ||
| MODERNA Aktie jetzt für 0€ handeln | |||||
| Sa | Curevac verklagt US-Konzern Moderna wegen Patentverletzungen | 111 | manager-magazin.de | ||
| Fr | CureVac sues Moderna for patent infringement over COVID-19 vaccines | 18 | Reuters | ||
| Fr | CureVac sues Moderna over mRNA vaccine patents | 13 | Investing.com | ||
| Fr | CureVac verklagt Moderna wegen Patentverletzung bei mRNA-Impfstoffen | 34 | Investing.com Deutsch |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| 14:00 | RedHill Biopharma Ltd.: RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights | PR Newswire | 2025 was a year of tenacity, strategic transactions and building traction for RedHill
Talicia® business transformed:
Formation of Talicia Holdings Inc. (THI) and... ► Artikel lesen | |
| 14:30 | Morning Market Movers: Sagimet Biosciences, Compass Therapeutics, Oruka Therapeutics, Veradermics See Big Swings | AFX News | SAN DIEGO (dpa-AFX) - At 8:00 a.m. ET on Monday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 15:09 | EQS-News: GeoVax, Inc.: GeoVax Highlights Gedeptin(R) as a Potential Immune-Sensitizing Platform Amid Rising Industry Investment in In Vivo Cancer Therapies | EQS Group (EN) | EQS-News: GeoVax, Inc.
/ Key word(s): Financial
GeoVax Highlights Gedeptin(R) as a Potential Immune-Sensitizing Platform Amid Rising Industry Investment in In Vivo Cancer Therapies... ► Artikel lesen | |
| 14:10 | Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer | GlobeNewswire (Europe) | Management remit expansion reflecting organization alignment to maximize external engagement and strategy execution
COPENHAGEN, Denmark, April 27, 2026 - Evaxion A/S (NASDAQ: EVAX) ("Evaxion"),... ► Artikel lesen | |
| 14:02 | Hypha Labs, Inc.: Trump Psychedelic Executive Order Accelerates Industry Growth | ACCESS Newswire | Hypha Labs, Inc. (FUNI) Positioned to Lead with AI-Driven Production Technology LAS VEGAS, NV / ACCESS Newswire / April 27, 2026 / Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology innovator focused on... ► Artikel lesen |